|
|
|
|
For the years ended December 31, |
|
|||||||
|
|
|
|
2017 |
|
2016 |
|
2015 |
|
|||
|
|
COST OF GOODS SOLD |
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation |
|
$ |
59,115 |
|
$ |
209,613 |
|
$ |
165,884 |
|
|
|
Share-based payments |
|
|
70,242 |
|
|
45,803 |
|
|
310,360 |
|
|
|
Cash-based employee expenses |
|
|
2,595,654 |
|
|
2,753,841 |
|
|
3,070,566 |
|
|
|
Other expenses |
|
|
752,810 |
|
|
4,082,504 |
|
|
3,391,324 |
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
$ |
3,477,821 |
|
$ |
7,091,761 |
|
$ |
6,938,134 |
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
EXPENSES |
|
|
|
|
|
|
|
|
|
|
|
|
Selling expenses |
|
|
|
|
|
|
|
|
|
|
|
|
Share-based payments |
|
$ |
98,379 |
|
$ |
138,334 |
|
$ |
120,780 |
|
|
|
Cash-based employee expenses |
|
|
202,261 |
|
|
109,150 |
|
|
31,447 |
|
|
|
Other expenses |
|
|
585,586 |
|
|
449,154 |
|
|
503,442 |
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
886,226 |
|
|
696,638 |
|
|
655,669 |
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
General and administrative expenses |
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation |
|
|
93,196 |
|
|
119,977 |
|
|
78,544 |
|
|
|
Share-based payments |
|
|
1,080,627 |
|
|
510,508 |
|
|
1,323,583 |
|
|
|
Cash-based employee expenses |
|
|
2,792,897 |
|
|
2,713,110 |
|
|
2,128,392 |
|
|
|
Litigation expenses |
|
|
2,410,350 |
|
|
13,170,138 |
|
|
7,058,226 |
|
|
|
Expenses related to the financing |
|
|
5,447,182 |
|
|
— |
|
|
— |
|
|
|
Other expenses |
|
|
3,860,531 |
|
|
2,669,054 |
|
|
3,324,331 |
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
15,684,783 |
|
|
19,182,787 |
|
|
13,913,076 |
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
Product development and clinical trials expenses |
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation |
|
|
382,234 |
|
|
426,144 |
|
|
259,281 |
|
|
|
Share-based payments |
|
|
1,235,294 |
|
|
1,115,466 |
|
|
2,359,442 |
|
|
|
Cash-based employee expenses |
|
|
4,971,668 |
|
|
6,183,013 |
|
|
5,000,258 |
|
|
|
Other expenses |
|
|
10,899,896 |
|
|
11,639,880 |
|
|
9,562,414 |
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
17,489,092 |
|
|
19,364,503 |
|
|
17,181,395 |
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
TOTAL EXPENSES |
|
$ |
34,060,101 |
|
$ |
39,243,928 |
|
$ |
31,750,140 |
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
Depreciation per Statements of Cash Flows |
|
$ |
534,545 |
|
$ |
755,734 |
|
$ |
503,709 |
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
Share-based payments per Statements of Cash Flows |
|
$ |
2,484,542 |
|
$ |
1,810,111 |
|
$ |
4,114,165 |
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
Cash-based employee expenses (see Note 19) |
|
$ |
10,562,480 |
|
$ |
11,759,114 |
|
$ |
10,230,663 |
|
|
|
|
|
|
|
|
|
|
|
|||